Imuno Therapeutics
Machine learning cancer discovery
- B2B
About Imuno Therapeutics
Pioneers machine learning for structure-based discovery engine, identifying cancer-specific epitopes for novel therapeutic strategies, unique to patient's tumor, best properties for targeting.
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Leiden, Zuid-Holland, Netherlands
- Founded
- 2020
- Revenue
- $6.7M – $52.7MTamtam estimate
- Website
- imunotx.com
Imuno Therapeutics at a glance
Imuno Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Leiden, Zuid-Holland, Netherlands.
Imuno Therapeutics was founded in 2020.
Imuno Therapeutics has 11–50 employees.
Imuno Therapeutics's revenue is $6.7M – $52.7M (Tamtam estimate).
Frequently asked questions about Imuno Therapeutics
What is Imuno Therapeutics's revenue?
Tamtam estimates Imuno Therapeutics's annual revenue at $6.7M – $52.7M.
How many employees does Imuno Therapeutics have?
Imuno Therapeutics has 11–50 employees.
Where is Imuno Therapeutics headquartered?
Imuno Therapeutics is headquartered in Leiden, Zuid-Holland, Netherlands.
Selling to companies like Imuno Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies